drugset / Trial / NCT00754208

Long Acting Stimulant Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Young Children

NCT00754208 ↗

Phase 4 Completed 7 enrolled University of Nebraska
NaSingle-groupOpen-labelTreatment

Summary

This is a pilot study evaluating the effectiveness, safety, and tolerability of Ritalin LA in treating Attention Deficit Hyperactivity Disorder (ADHD) in 4 and 5 year old children. Virtually no data has been published on the use of long-acting stimulant preparations in very young children despite early symptomatic development in a significant portion of young children with ADHD. This would be one of the first studies looking at a long-acting preparation of a stimulant medication in the treatment of ADHD in very young children. Hypotheses 1. Ritalin LA is effective for the treatment of ADHD in 4 and 5 year old children. 2. Ritalin LA is reasonably well-tolerated in the treatment of ADHD in 4 and 5 year old children.

Timeline

Start
2008-09-18
Primary completion
2010-01-01
Completion
2010-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylphenidate Small molecule 1 mg/kg Oral